HORIZON-HLTH-2022-DISEASE-06-02-two-stage

December 23, 2021

​Health; Destination 3: Tackling diseases and reducing disease burden.
Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

Scope: Immunotherapy is defined as a treatment able to stimulate or restore the ability of the immune (defence) system to fight infection, disease or disorder. It has proved to be a valuable medical treatment notably when preventive interventions are not available. Passive and active immunotherapies (such as antibody-based, RNA-based and cell-based therapies, respectively) are covered by this topic, which is aiming at the pre-clinical to first-in human development of next generation immunotherapies for unmet needs.

Preclinical development and study of new immunotherapeutic agents in vitro and in relevant animal model(s) of the disease(s). This includes understanding of the therapy’s agent(s) mode of action, its toxicity, the development of related potency assay(s), and its/their validation in vitro and in vivo.

Project budget: 6M (Total budget 60M); Deadline: 1 February 2022 (1st stage), 6 September 2022 (2nd stage). More

Become a member

You are not a member yet? Subscribe here to join the OoC community.

Join us

Stay tuned

Become a member
WHAT IS THE ADVANTAGE OF JOINING THE OoC COMMUNITY ? registration

Academic

  • Keep up to date on the latest news and events
  • Share information
  • Find expertise/collaboration

 

Industrial

  • Keep informed about new scientific and technological developments
  • Find academic/private partners
  • Gain in visibility and awareness of your activity

Individual

  • Get a better understanding of OoC field (applications, challenges)
  • Be updated about OoC
  • Be part of the network

Sentence about data protection vocabulo circulo abdita lunari semper theologi etiam alii filiam duplici.

Academic

Keep up to date on the latest news and events

Personalized subscription fees (in progress):

  • Free Membership

  • Premium Membership







Sentence about data protection vocabulo circulo
abdita lunari semper theologi etiam alii filiam
duplici.

Industrial

Keep informed about new scientific and technological developments

Personalized subscription fees (in progress):

  • Free Membership

  • Premium Membership







Sentence about data protection vocabulo circulo
abdita lunari semper theologi etiam alii filiam
duplici.

Individual

Be updated about OoC / Get a better understanding of OoC

Personalized subscription fees (in progress):

  • Free Membership

  • Premium Membership







Sentence about data protection vocabulo circulo
abdita lunari semper theologi etiam alii filiam
duplici.

Reserved
ACCESS

Return
Join us !

Would you like to know more ?
Join us and share the latest advances in OoC Research, be informed about emerging OoC projects, about who are the European leading experts, the novel applications, partners and much more

(Note: free membership gives you access to the library)

OR

Connect to your personal space

Forgot your password?
OR